Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies

The Evolution of Multimodality Therapy for Malignant Pleural Mesothelioma

(2011) Marjorie G. Zauderer et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Management of Thymic Tumors: A Survey of Current Practice among Members of the European Society of Thoracic Surgeons

(2011) Enrico Ruffini et al.   Journal of Thoracic Oncology

Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma: A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group

(2011) David Rice et al.   Journal of Thoracic Oncology

Multimodal treatment for stage IVA thymoma: A proposable strategy

(2011) Ottavio Rena et al.   LUNG CANCER

Surgical Resection of Thymoma Still Represents the First Choice of Treatment

(2011) M. Ried et al.   THORACIC AND CARDIOVASCULAR SURGEON

Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study

(2009) Tamara R. Tilleman et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma

(2009) Lambros Zellos et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

The Mesothelioma and Radical Surgery Randomized Controlled Trial: The MARS Feasibility Study

(2009) Tom Treasure et al.   Journal of Thoracic Oncology

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

(2008) Martin F Muers et al.   LANCET